Osasen Sensores

What Osasen Sensores does

Osasen Sensores, operating commercially as BIOLAN HEALTH, is a privately-held Spanish in vitro diagnostics company headquartered at the Bizkaia Technology Park in Zamudio, Spain. The company develops point-of-care (POC) diagnostic devices and systems based on two underlying technology platforms: enzymatic biosensors and lateral flow immunoassays. Its products are positioned as rapid, reliable, and cost-effective tools intended to support clinical decision-making across diagnosis, prevention, and health monitoring use cases, with applications spanning hospitals, clinical laboratories, pharmaceutical and biotech firms, universities, and workplace health programs.

The product portfolio comprises two core offerings. The OSAXYL 7000 is a portable enzymatic biosensor that supports diagnosis of hypolactasia (lactose intolerance) by detecting xylose in urine following ingestion of the LacTEST drug. The BIOLAN HEALTH COVID-19 Antigen Rapid Test-Self Test is a lateral flow immunoassay designed for at-home detection of SARS-CoV-2 infection. The company manufactures its products in-house as a licensed medical device manufacturer, with the sanitary authorization granted by the Spanish Agency for Medicines and Medical Products (AEMPS) in 2018. No patents, trademarks, proprietary datasets, or other intangible asset disclosures are present in the available sources.

BIOLAN HEALTH operates a direct B2B sales model targeting five customer segments: hospitals and healthcare centers, pharmaceutical and biotechnology companies, clinical analysis laboratories, universities and research centers, and private companies. Distribution is conducted through the company website, phone, and email channels, with operations concentrated in the domestic Spanish market. No public pricing, customer logos, headcount, funding history, or revenue figures are disclosed, and the company shows no signs of international expansion, institutional capital, or active partnership activity in the available data.

Name

Osasen Sensores

Legal name

Osasen Sensores

Website

https://osasen.com

Company type

Private

Operating status

Operating

Short description

Osasen Sensores, operating as BIOLAN HEALTH, is a Spain-based developer of point-of-care in vitro diagnostic devices using enzymatic biosensors and lateral flow immunoassays. It serves hospitals, clinical laboratories, pharmaceutical firms, and research institutions in the domestic Spanish market.

Ownership category

akta.pro rank

Product category

Point-of-Care Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Electromedical & Electrotherapeutic Apparatus (3845), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

Keywords

• Point-of-care diagnostics
• Enzymatic biosensors
• Lateral flow immunoassays
• In vitro diagnostics
• Rapid diagnostic testing

Headquarters

HQ city

Derio

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Distribution channels2 records

Marketing channels2 records

Core offering

Osasen Sensores (operating commercially as BIOLAN HEALTH) develops, manufactures, and commercializes point-of-care (POC) diagnostic devices and systems based on enzymatic biosensors and lateral flow immunoassays for in vitro diagnostic applications. Its commercial portfolio includes the OSAXYL 7000 enzymatic biosensor for the diagnosis of hypolactasia (lactose intolerance) and the BIOLAN HEALTH COVID-19 Antigen Rapid Test for self-testing.

Product overview

BIOLAN HEALTH develops point-of-care (POC) diagnostic devices based on enzymatic biosensors and lateral flow immunoassays. The product portfolio includes the OSAXYL 7000 enzymatic biosensor for lactose intolerance diagnosis and the BIOLAN HEALTH COVID-19 Antigen Rapid Test for self-testing. These rapid, reliable, and cost-effective in vitro diagnostic tools are designed for health monitoring, detection, and decision-making in diagnosis, prevention, and health follow-up.

Differentiator

Problem solved

Functional benefit

Brands

• OSAXYL 7000: Biosensor enzimático para el diagnóstico de hipolactasia (intolerancia a la lactosa) mediante la detección de xilosa en orina.

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• SD Biosensor: Korea-headquartered manufacturer of rapid diagnostic kits and POC immunoassay systems including COVID-19 antigen and antibody tests. Direct comparable in lateral flow technology and IVD product categories, although at materially larger scale.
• Biosynex: France-listed rapid diagnostics company selling lateral flow tests for infectious diseases (including COVID-19), pregnancy, and other parameters. Comparable as a small-to-mid European POC IVD manufacturer with a similar go-to-market focus on rapid tests and self-testing.
• EKF Diagnostics Holdings: UK-listed manufacturer of POC diagnostic devices including point-of-care biosensors, hemoglobin analyzers, and rapid test kits for clinical and home use. Comparable in size and product mix, with a similar dual platform of analyzers and lateral flow consumables.
• GenBody Inc. Korea-based manufacturer of in vitro diagnostic rapid test kits including COVID-19 antigen, influenza, and infectious disease assays. Comparable as a focused lateral flow IVD manufacturer operating in similar product categories to BIOLAN's COVID self-test.
• Abingdon Health: UK-based lateral flow contract developer and IVD manufacturer serving clinical, veterinary, and at-home diagnostic markets. Highly comparable as a small-to-mid European firm commercializing lateral flow immunoassay platforms including COVID-19 antigen tests.
• Global Access Diagnostics (formerly Mologic): UK-based POC diagnostics company developing lateral flow and rapid diagnostic tests including COVID-19 antigen assays for global health and clinical use. Directly comparable technology and end-markets to BIOLAN's lateral flow product.

Broad incumbents

• Siemens Healthineers: Global IVD and medical imaging leader with POC and central lab diagnostic solutions. While BIOLAN operates at a vastly smaller scale, Siemens competes for the same hospital and clinical lab customers with broader menus and integrated platform offerings.
• bioMérieux: France-headquartered in vitro diagnostics leader focused on microbiology, infectious disease, and industrial applications. Represents the broader IVD incumbent tier competing for clinical lab and hospital accounts relevant to BIOLAN's customer segments.
• QuidelOrtho: US-listed diagnostics company combining Quidel's rapid immunoassay portfolio (including Sofia COVID-19 antigen tests) with Ortho's clinical chemistry and immunoassay systems. Overlaps directly with BIOLAN's lateral flow and POC offerings but operates at enterprise scale.
• Abbott Diagnostics (including Alere): Global leader in POC diagnostics through its Alere acquisition, offering rapid tests, biosensors (e.g., i-STAT), and a comprehensive IVD menu. Competes broadly with BIOLAN's product categories but with vastly greater R&D, manufacturing, and global distribution scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Osasen Sensores